vida: extract claims from 2026-04-30-phti-glp1-employer-scope-large-vs-small-behavioral-mandate
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
- Source: inbox/queue/2026-04-30-phti-glp1-employer-scope-large-vs-small-behavioral-mandate.md - Domain: health - Claims: 0, Entities: 0 - Enrichments: 2 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
This commit is contained in:
parent
2da4f7b73f
commit
464b2ad5df
3 changed files with 20 additions and 3 deletions
|
|
@ -11,7 +11,7 @@ sourced_from: health/2026-04-28-phti-employer-glp1-coverage-behavioral-mandate-2
|
||||||
scope: structural
|
scope: structural
|
||||||
sourcer: Peterson Health Technology Institute
|
sourcer: Peterson Health Technology Institute
|
||||||
supports: ["glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024"]
|
supports: ["glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024"]
|
||||||
related: ["glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk", "comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation", "digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring", "glp1-year-one-persistence-doubled-2021-2024-supply-normalization", "glp-1-therapy-requires-nutritional-monitoring-infrastructure-but-92-percent-receive-no-dietitian-support", "glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift", "glp1-managed-access-operating-systems-require-multi-layer-infrastructure-beyond-formulary"]
|
related: ["glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk", "comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation", "digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring", "glp1-year-one-persistence-doubled-2021-2024-supply-normalization", "glp-1-therapy-requires-nutritional-monitoring-infrastructure-but-92-percent-receive-no-dietitian-support", "glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift", "glp1-managed-access-operating-systems-require-multi-layer-infrastructure-beyond-formulary", "glp1-employer-coverage-declining-despite-utilization-growth-creating-access-gap"]
|
||||||
---
|
---
|
||||||
|
|
||||||
# GLP-1 behavioral support mandates tripled in one year (10% to 34%) signaling structural shift from drug-only formulary to managed-access operating systems
|
# GLP-1 behavioral support mandates tripled in one year (10% to 34%) signaling structural shift from drug-only formulary to managed-access operating systems
|
||||||
|
|
@ -24,3 +24,10 @@ PHTI's December 2025 employer survey found that 34% of firms covering GLP-1s now
|
||||||
**Source:** DistilINFO April 2026 citing Leverage|Axiaci December 2025
|
**Source:** DistilINFO April 2026 citing Leverage|Axiaci December 2025
|
||||||
|
|
||||||
The behavioral mandate acceleration (34% of employers requiring support, up from 10%) is occurring simultaneously with a 22% decline in total covered lives (3.6M to 2.8M), suggesting market bifurcation: large sophisticated employers add managed-access infrastructure while regional payers and mid-market employers drop coverage entirely. The two trends are compatible but create divergent access pathways.
|
The behavioral mandate acceleration (34% of employers requiring support, up from 10%) is occurring simultaneously with a 22% decline in total covered lives (3.6M to 2.8M), suggesting market bifurcation: large sophisticated employers add managed-access infrastructure while regional payers and mid-market employers drop coverage entirely. The two trends are compatible but create divergent access pathways.
|
||||||
|
|
||||||
|
|
||||||
|
## Extending Evidence
|
||||||
|
|
||||||
|
**Source:** PHTI December 2025 Employer GLP-1 Approaches Report + Mercer 2026
|
||||||
|
|
||||||
|
PHTI December 2025 report confirms 34% of employers requiring behavioral support as GLP-1 coverage condition (up from 10% — 3.4x in one year). Critical scope qualification: this applies to LARGE employers (500+ employees or self-insured) who have already chosen to cover GLP-1s. Survey methodology covers employer-sponsored plans with sufficient scale to administer condition-based coverage. Mercer 2026 data shows 90% of large employers plan to continue GLP-1 coverage through 2026, 86% of mid-market employers continuing. The behavioral mandate represents cost management within continuing coverage, not coverage elimination.
|
||||||
|
|
|
||||||
|
|
@ -12,7 +12,7 @@ scope: structural
|
||||||
sourcer: DistilINFO Publications
|
sourcer: DistilINFO Publications
|
||||||
supports: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk"]
|
supports: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk"]
|
||||||
challenges: ["GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035"]
|
challenges: ["GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035"]
|
||||||
related: ["GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "medicaid-glp1-coverage-reversing-through-state-budget-pressure", "glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift", "glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost", "glp1-managed-access-operating-systems-require-multi-layer-infrastructure-beyond-formulary"]
|
related: ["GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "medicaid-glp1-coverage-reversing-through-state-budget-pressure", "glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift", "glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost", "glp1-managed-access-operating-systems-require-multi-layer-infrastructure-beyond-formulary", "glp1-employer-coverage-declining-despite-utilization-growth-creating-access-gap"]
|
||||||
---
|
---
|
||||||
|
|
||||||
# GLP-1 weight-loss coverage is declining at the employer and health system level despite rising utilization creating a widening access gap driven by cost pressures that exceed VBC cost management capacity
|
# GLP-1 weight-loss coverage is declining at the employer and health system level despite rising utilization creating a widening access gap driven by cost pressures that exceed VBC cost management capacity
|
||||||
|
|
@ -25,3 +25,10 @@ Covered individuals enrolled in employer-sponsored GLP-1 weight-loss coverage de
|
||||||
**Source:** HR Brew December 2025, Q4 2025-Q1 2026 employer benefits data
|
**Source:** HR Brew December 2025, Q4 2025-Q1 2026 employer benefits data
|
||||||
|
|
||||||
Covered lives declined from 3.6M to 2.8M (22% drop) while utilization among those with coverage more than doubled since 2023, reaching 49% in surveyed populations. This confirms the utilization/coverage divergence: higher usage among those who maintain access, but total population-level coverage shrinking due to cost pressure on health systems and regional payers.
|
Covered lives declined from 3.6M to 2.8M (22% drop) while utilization among those with coverage more than doubled since 2023, reaching 49% in surveyed populations. This confirms the utilization/coverage divergence: higher usage among those who maintain access, but total population-level coverage shrinking due to cost pressure on health systems and regional payers.
|
||||||
|
|
||||||
|
|
||||||
|
## Extending Evidence
|
||||||
|
|
||||||
|
**Source:** PHTI December 2025 + Mercer 2026
|
||||||
|
|
||||||
|
Scope resolution: the 3.6M → 2.8M covered lives decline (22% reduction) applies to different populations than the 34% behavioral mandate increase. Population experiencing coverage loss: health system-employed populations (Allina, RWJBarnabas, Ascension), state government employees (4 states withdrawing), Kaiser California Medicaid/commercial eliminations, regional and small-group insurers restricting small employer plans. Mass General Brigham Health Plan example: small employers (under 50 subscribers) no longer offered GLP-1 obesity coverage as of January 1, 2026; employers with 50+ subscribers offered as add-on option. This is employer size bifurcation, not a contradiction — large sophisticated employers keep coverage with conditions while small group plans eliminate coverage entirely.
|
||||||
|
|
|
||||||
|
|
@ -7,10 +7,13 @@ date: 2025-12
|
||||||
domain: health
|
domain: health
|
||||||
secondary_domains: []
|
secondary_domains: []
|
||||||
format: report
|
format: report
|
||||||
status: unprocessed
|
status: processed
|
||||||
|
processed_by: vida
|
||||||
|
processed_date: 2026-04-30
|
||||||
priority: high
|
priority: high
|
||||||
tags: [glp-1, employer-coverage, behavioral-mandate, large-employer, small-employer, scope, parity, obesity]
|
tags: [glp-1, employer-coverage, behavioral-mandate, large-employer, small-employer, scope, parity, obesity]
|
||||||
intake_tier: research-task
|
intake_tier: research-task
|
||||||
|
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||||
---
|
---
|
||||||
|
|
||||||
## Content
|
## Content
|
||||||
Loading…
Reference in a new issue